Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02004158 · ClinicalTrials.gov registry record · NA

Positive Psychology to Improve Healthy Behaviors After an Acute Coronary Syndrome

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT02004158: Completed NA study, sponsored by Massachusetts General Hospital.

NCT02004158 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02004158, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

In this proof-of-concept study, the investigators will assess the ease and usefulness of a positive psychology program in patients with acute coronary syndrome and less-than-optimal adherence to health behaviors. The investigators believe that positive psychology (a field that studies boosting positive emotions rather than simply reducing negative emotions) will help this cardiac population to be more healthy. The investigators want to determine whether this positive psychology program has the potential to be an adjunctive treatment for cardiac populations.

Primary Outcome

Rate of exercise completion will be measured by the number of participants who have a good rate of completion of exercises. There are 8 exercises in total. A good rate of completion will be defined as an average of 5 or more exercises completed per subject.

Interventions

  • BEHAVIORAL Positive psychology intervention

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2013-11
Est. Completion 2014-09
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT02004158 record still lists

NCT02004158 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Positive psychology intervention is the first listed.

NCT02004158 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02004158 about?

NCT02004158 is a clinical study titled "Positive Psychology to Improve Healthy Behaviors After an Acute Coronary Syndrome". In this proof-of-concept study, the investigators will assess the ease and usefulness of a positive psychology program in patients with acute coronary syndrome and less-than-optimal adherence to health behaviors. The investigators believe that positive psychology (a field that studies boosting posit...

What is the current status of trial NCT02004158?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2013-11. Estimated completion is 2014-09.

What interventions are being tested in trial NCT02004158?

The interventions under investigation include: Positive psychology intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02004158?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02004158's enrollment target sits among peer trials

23 1755th of 2000 higher than 245 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02004158, the US trial registry maintained by the National Library of Medicine. NCT02004158 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.